Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

May 10, 2011

NFTE Philadelphia to Honor GSI Commerce’s Michael G. Rubin at this year’s Visionary Gala

It’s a busy time of the year for NFTE Philadelphia. In-school business plan competitions just concluded at the 15 schools where the NFTE program is…

Posted by Peter J. Boni

May 5, 2011

Safeguard Scientifics Honored with Investment Deal of the Year at PACT Enterprise Awards

Last night, I had the pleasure of attending the Greater Philadelphia Alliance for Capital and Technologies (PACT) 18th Annual Enterprise Awards. For nearly 60 years,…

Posted by Peter J. Boni

January 17, 2011

2010 Achievements and 2011 Outlook: Safeguard Scientifics, Capital Markets, Regulatory Compliance and more

Last year around this time, as we headed into 2010 and were making plans for the coming year, we were in the midst of the…

Posted by Peter J. Boni

December 30, 2010

Challenges for Corporate CEOs in 2011

2010 was a trying year for every business. Even with the recent glimmers of economic improvement, 2011 will be no less challenging. I was recently…

Posted by Peter J. Boni

December 21, 2010

Clarient and Avid Radiopharmaceuticals Complete Acquisitions

Earlier this quarter, we announced that partner companies Clarient (Nasdaq: CLRT) and Avid Radiopharmaceuticals had signed definitive agreements to be acquired by GE Healthcare and…

Posted by Peter J. Boni

November 10, 2010

NFTE Philadelphia Visionary Gala 2010: Honoring Those Who Give Back

A few months ago, I wrote about a partnership that means a great deal to me and to my colleagues at Safeguard Scientifics — the…

Posted by Peter J. Boni

November 8, 2010

Eli Lilly Agrees to Acquire Safeguard Scientifics Partner Company Avid Radiopharmaceuticals

For the second time in as many weeks, I am pleased to announce that a major player in the pharmaceutical industry has recognized the value…

Posted by Peter J. Boni

October 22, 2010

Partner Company Clarient (Nasdaq: CLRT) to be Acquired by GE Healthcare for $587 Million

At Safeguard Scientifics, our strategy is to provide growth capital for entrepreneurial and innovative life sciences and technology companies, build value in those companies and…

Posted by Peter J. Boni

October 20, 2010

Third Quarter 2010 Trends in Venture Capital

According to the latest MoneyTree survey conducted by PricewaterhouseCoopers and the National Venture Capital Association, venture capital investing in the third quarter of 2010 was…

Posted by Peter J. Boni